Aurobindo Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Profit before tax

2,358.45

2,402.92

1,614.35

1,637.48

4,193.01

Net cashflow-operating activity

1,645.79

1,714.80

1,821.16

3,726.71

2,994.41

Net cash used in investing activity

-2,065.90

-159.96

-3,459.68

-1,613.51

-2,648.73

Netcash used in fin. activity

616.31

-1,837.03

1,719.48

-2,447.54

-27.94

Net inc/dec in cash and equivlnt

211.94

-273.81

81.44

-335.37

316.23

Cash and equivalnt begin of year

83.32

357.13

48.21

383.58

67.35

Cash and equivalnt end of year

295.26

83.32

129.65

48.21

383.58